"HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"

Clinical trial NCT06800404 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06800404
Sponsor: Hope Biosciences Research Foundation
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis (RRMS)Multiple Sclerosis

Start date: 2025-05-02
Primary completion: 2027-01-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.